Vaccination News Home Page subscribe Vaccination NewsLetter
http://query.nytimes.com/search/full-page?res=9F0CE6DF1239F932A05750C0A9659C8B63
March 31, 2003, Monday
BUSINESS/FINANCIAL DESK
Study Said to Back Guidant Artery Device
CHICAGO, March 30 -- Researchers presented new evidence today that a minimally invasive technique might be the best way to treat high-risk patients with clogged arteries in the neck who are at risk of a stroke. The study, released at a meeting of cardiologists in Chicago, showed patients who were poor candidates for surgery fared well when tiny, wire-mesh tubes called stents were implanted to prop open clogged carotid arteries.
A trial of 513 patients treated with a stent found the procedure to be safe and effective at treating those who are at high risk in about 92 percent of cases.
Guidant, a medical device maker, sponsored the study, which used the company's Acculink carotid stent system. The device includes a trap that collects fatty deposits loosened during stent placement before they can make their way to the brain.
In November, Johnson & Johnson released results from a similar trial showing the treatment was effective.
Some rivals, Boston Scientific, Medtronic and C. R. Bard, have clinical trials under way using stents to treat carotid arteries.
Published: 03 - 31 - 2003 , Late Edition - Final , Section C , Column 3 , Page 8
Copyright 2002 The New York Times Company |
Privacy Information
ALL INFORMATION, DATA, AND
MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR GENERAL INFORMATION
PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE KNOWLEDGE OR OPINIONS
OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED AS PROVIDING MEDICAL OR
LEGAL ADVICE. THE DECISION WHETHER OR NOT TO VACCINATE IS AN IMPORTANT AND
COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU ALONE, IN CONSULTATION WITH
YOUR HEALTH CARE PROVIDER.